Sterling Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.1M | Buy |
20,444
+8,070
| +65% | +$3.59M | 0.13% | 107 |
|
|
2025
Q1 | $6M | Buy |
12,374
+375
| +3% | +$182K | 0.09% | 126 |
|
|
2024
Q4 | $4.83M | Sell |
11,999
-291
| -2% | -$117K | 0.07% | 227 |
|
|
2024
Q3 | $5.72M | Buy |
+12,290
| New | +$5.72M | 0.07% | 184 |
|
|
2017
Q3 | – | Sell |
-2,020
| Closed | -$260K | – | 980 |
|
|
2017
Q2 | $260K | Buy |
+2,020
| New | +$260K | ﹤0.01% | 848 |
|
|
2014
Q3 | – | Sell |
-2,911
| Closed | -$276K | – | 961 |
|
|
2014
Q2 | $276K | Buy |
+2,911
| New | +$276K | ﹤0.01% | 820 |
|